Antisense-Pharma Video

Recent Police Force News:

????? ??????? ?????? - ????? 1

????? ??????? ?????? - ????? 3

Antisense - Kampf dem Krebs

Kreidezeit 31: Antisense-Technik

Leaders from Drug Delivery Industry to Discuss Advances in Biotech, Nanotech and Targeted Delivery Technologies at Arrowhead's 3rd Annual Drug D
Arrowhead's 3rd Annual Drug Delivery Summit, scheduled to take place in San Francisco, CA on May 14th and May 15th, 2009, will be bringing together leaders from the drug delivery industry to discuss the newest and most important advances being made in the field of drug delivery.

Scholarship Honours York University Chemistry Professor
Peter Pekos, president and CEO of Dalton Pharma Services, has established a new scholarship to benefit chemistry students at York University in Toronto, in honour of his former mentor and business partner, Dr. Douglas Butler.

Arrowhead Releases New Report Assessing State of Personalized Medicine Market
The era of Personalized Medicine is set to revolutionize the healthcare industry. As our knowledge of genetics and molecular biology rapidly expands, a personalized approach to medical care is becoming increasingly important.

US Patent Granted To Chrono Therapeutics Inc. For Its Chrono-Pharmacological Drug Delivery Systems And Applications
Patent Protection extends at least to 2025

Scientific and Business Leaders to Discuss Challenges Facing Developers of Pain Therapeutics at Arrowhead’s 4th Annual Pain Therapeutics Summit
Now in its 4th year, Arrowhead's Annual Pain Therapeutics Summit continues to attract both academic and industry leaders from around the globe to discuss pain management, preclinical and clinical development of new pain therapeutics.

Global Market for Hepatitis C Virus Therapeutics to Reach $9.1 billion by 2015, According to New Report by Global Industry Analysts
The HCV therapeutic development landscape continues to inflate and currently possesses three compounds in Phase III clinical studies, several novel therapies in Phase II and Phase I pipeline, and numerous new compounds in animal-stage study and research stages. Driven by the new drug launches, the global HCV therapeutics market is forecast to reach $9.1 billion by 2015.

Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
Dalton Pharma Services announces the renewal of its Chemistry Services Agreement with Boehringer Ingelheim (Canada) Ltd. Under the agreement Dalton will continue to provide chemistry services in support of Boehringer's pharmaceutical development programs.

Global Multiple Sclerosis Therapeutics Market to Exceed $12.5 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Multiple Sclerosis market. The world market for multiple sclerosis therapeutics is projected to exceed $12.5 billion by the year 2015. With prevalence of the disease growing and presence of high-unmet need, demand for innovative and improved therapeutics to treat multiple sclerosis is increasing, presenting greater prospects for market growth.

cordblood.asia

antisensedrugs.com
The antisense drug resource

adultstemcell.org
The adult stem cell forum

bionews.org

drugengineering.com